Drug Target Review2026-05-15T09:31:00
A*STAR scientists have developed sm-PORE-cupine, a nanopore-based sequencing method that maps individual RNA structures at single-molecule resolution.
The technology combines chemical labelling with direct RNA sequencing to reveal how structural variations influence protein production, RNA stability and disease pathogenesis, with potential applications in antiviral development and precision therapeutics.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-06T07:26:00Z
Author Dr Tina Rogers
2026-11-03T12:09:00Z
2026-10-30T07:30:00
Sponsored by Aptamer Group
2026-08-26T07:00:00
Contributor Professor Paul O’Reilly, Drug Target Review
2026-08-24T08:43:00
Author Dr Dana Watt
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-03-23T14:46:21
Sponsored by Bio-Techne
Site powered by Webvision Cloud